3 Firms Seek $4M For CytoDyn Stock Award Suit Settlement

By Rose Krebs (March 22, 2021, 4:31 PM EDT) -- Three firms told the Delaware Chancery Court on Friday they are seeking $4.1 million in fees in connection with a proposed stockholder suit settlement that will require five directors of life sciences venture CytoDyn Inc. to forfeit "extremely lucrative awards" they allegedly unfairly received....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!